
effect dehydroepiandrosterone dehydroxycorticosteroids 
plasms various stages breast cancer mastopathy . 
  depressing effect dehydroepiandrosterone plasma 
corticosteroids is, average, shortened advanced breast cancer 
(stage iv) . lowest corticosteroid values found 
three groups patients 6 hours infusion 
dehydroepiandrosterone phosphate . effect dehydroepiandrosterone 
being, still provable 12 hours group suffering 
mastopathy, breast cancer group stage iv time already 
reached level initial values . breast cancer group 
stage iv time already reached level initial 
values . breast cancer group stage i/ii behaved intermediately . 
less lasting effect dehydroepiandrosterone attributed 
accelerated transformation advanced breast cancer . 
